About the AuthorMy name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
My ProfileI am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!
About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
Monthly Archives: May 2014
This is just awful. A whole week without a posting. Not because I did not have anything to talk about, but because I did not have anything like time on my side. It was one of those weeks. I did … Continue reading
We were all feeling a little pent up this Winter and delighted to see Spring. And what is more delightful than seeing others delighted? Check out the Weekly Roundup video of dairy cows greeting the meadow after a winter in … Continue reading
Accuracy and consistency in communications is always important. On important issues, misinformation can lead to serious consequences. That is especially true in the field of public health. In watching the media coverage of the outbreak of Middle East Respiratory Syndrome … Continue reading